Live Breaking News & Updates on Syros Pharmaceuticals Profile

Stay updated with breaking news from Syros pharmaceuticals profile. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Avidity Partners Management LP Has $13.04 Million Stock Holdings in Syros Pharmaceuticals, Inc. (NASDAQ:SYRS)

Avidity Partners Management LP increased its position in Syros Pharmaceuticals, Inc. (NASDAQ:SYRS – Free Report) by 5.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,673,538 shares of the company’s stock after purchasing an additional 92,396 shares during the […] ....

Piper Sandler , Securities Exchange Commission , Syros Pharmaceuticals Profile , Syros Pharmaceuticals , Bain Capital Life Sciences Investors , Syros Pharmaceuticals Stock Performance , Syros Pharmaceuticals Inc , News Ratings For Syros Pharmaceuticals Daily , Quarter For Syros Pharmaceuticals , Avidity Partners Management , Free Report , Partners Management , Capital Life Sciences Investors , Get Free Report , Visit Holdingschannel , Syros Pharmaceuticals Daily ,